BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28480630)

  • 1. A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in Systemic Lupus Erythematosus.
    Yelin E; Trupin L; Yazdany J
    Arthritis Rheumatol; 2017 Aug; 69(8):1612-1622. PubMed ID: 28480630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus.
    Heshin-Bekenstein M; Trupin L; Yelin E; von Scheven E; Yazdany J; Lawson EF
    Semin Arthritis Rheum; 2019 Oct; 49(2):267-272. PubMed ID: 31235075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.
    Yazdany J; Trupin L; Gansky SA; Dall'era M; Yelin EH; Criswell LA; Katz PP
    Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1170-7. PubMed ID: 21584946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.
    Drenkard C; Yazdany J; Trupin L; Katz PP; Dunlop-Thomas C; Bao G; Lim SS
    Arthritis Care Res (Hoboken); 2014 Jun; 66(6):888-96. PubMed ID: 24249662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Poverty and Mortality in Systemic Lupus Erythematosus.
    Yelin E; Yazdany J; Trupin L
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1101-1106. PubMed ID: 28973834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal validation of the Brief Index of Lupus Damage.
    Katz P; Trupin L; Rush S; Yazdany J
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1057-62. PubMed ID: 24376263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and evaluation of the German Brief Index of Lupus Damage (BILD)--a self-reported instrument to record damage in systemic lupus erythematosus.
    Chehab G; Sander O; Richter J; Acar H; Vordenbäumen S; Brinks R; Schneider M; Fischer-Betz R
    Lupus; 2013 Sep; 22(10):1050-5. PubMed ID: 23963433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study.
    Yazdany J; Trupin L; Schmajuk G; Katz PP; Yelin EH
    BMJ Qual Saf; 2014 Aug; 23(8):659-66. PubMed ID: 24614054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus.
    Brandt JE; Drenkard C; Kan H; Bao G; Dunlop-Thomas C; Pobiner B; Chang DJ; Jolly M; Lim SS
    Arthritis Care Res (Hoboken); 2017 Jun; 69(6):842-848. PubMed ID: 27564570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre.
    Hill DD; Eudy AM; Egger PJ; Fu Q; Petri MA
    Lupus Sci Med; 2021 Apr; 8(1):. PubMed ID: 33832976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
    Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Work disability in Argentinian patients with systemic lupus erythematosus is prevalent and it is due to ethnic, socioeconomic and disease-related factors.
    Pisoni CN; Muñoz SA; Tamborenea MN; García M; Curti A; Cappuccio A; Rillo O; Imamura PM; Schneeberger E; Ballent M; Cousseau ML; Velasco Zamora J; Saurit V; Toloza S; Danielsen MC; Bellomio VI; Graf C; Paira S; Cavallasca J; Pons Estel B; Moreno JLC; Díaz M; Alba P; Verando M; Tate G; Mysler E; Sarano J; Civit EE; Risueño F; Álvarez Sepúlveda P; Larroude MS; Méndez MF; Conforti A; Sohn D
    Int J Rheum Dis; 2018 Nov; 21(11):2019-2027. PubMed ID: 29611343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
    Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
    Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.
    Montes RA; Mocarzel LO; Lanzieri PG; Lopes LM; Carvalho A; Almeida JR
    Arthritis Rheumatol; 2016 Feb; 68(2):441-8. PubMed ID: 26359794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus.
    Kandane-Rathnayake R; Kent JR; Louthrenoo W; Luo SF; Wu YJ; Lateef A; Golder V; Sockalingam S; Navarra SA; Zamora L; Hamijoyo L; Katsumata Y; Harigai M; Chan M; O'Neill S; Goldblatt F; Lau CS; Hoi A; Nikpour M; Morand E
    Lupus; 2019 Dec; 28(14):1669-1677. PubMed ID: 31718467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus among male patients in Malaysia: how are we different from other geographical regions?
    Shaharir SS; Kadir WDA; Nordin F; Bakar FA; Ting MWH; Jamil A; Mohd R; Wahab AA
    Lupus; 2019 Jan; 28(1):137-144. PubMed ID: 30458692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.